Newsroom
Sorted by: Latest
-
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) (“Alkermes”) and Avadel Pharmaceuticals plc (Nasdaq: AVDL) (“Avadel”) today announced Alkermes’ completion of its acquisition of Avadel, a commercial-stage biopharmaceutical company. The acquisition adds Avadel’s FDA-approved product, LUMRYZ®, to Alkermes’ commercial portfolio, and provides Alkermes with a commercial organization experienced in this disease state. This strategic move accelerates Alkermes’ entry into the sleep medicine market...
-
Enhabit and Encompass Health Collect $43.1 Million from Individual Defendants in Delaware Fiduciary Breach Case
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) announced today that, along with Encompass Health Corporation (NYSE: EHC), they have collected $43.1 million in full satisfaction of their claims for attorneys’ fees and mitigation damages in the Delaware Court of Chancery against former officer Chris Walker, Vistria Group senior partner David Schuppan, and Nautic Partners managing director Christopher Corey. These claims related to the December 2024 judgment in favor of Enhabit and Encompass...
-
Sphere Entertainment Co. Reports Fourth Quarter and Full Year 2025 Results
NEW YORK--(BUSINESS WIRE)--Sphere Entertainment Co. (NYSE: SPHR) (“Sphere Entertainment” or the “Company”) today reported financial results for the fourth quarter and full-year ended December 31, 2025. Recent highlights for the Company’s Sphere segment include: In January, the Company announced with the State of Maryland, Prince George’s County, and Peterson Companies the intent to develop a new Sphere venue – which would be the second in the U.S. and first to utilize a smaller-scale design mod...
-
VSE Corporation Announces Fourth Quarter and Full Year 2025 Results Conference Call Date
MIRAMAR, Fla.--(BUSINESS WIRE)--VSE Corporation (“VSE” or the “Company”) (NASDAQ: VSEC), a leading provider of aviation aftermarket distribution and repair services, announced today that it will issue fourth quarter and full year 2025 results after the market close on Wednesday, February 25, 2026. A conference call will be held on Thursday, February 26, 2026, at 8:30 A.M ET to review the Company’s financial results, discuss events, and conduct a question-and-answer session. An audio webcast of...
-
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon announces Q4 2025 and Full Year 2025 earnings results, ending December 31, 2025....
-
Soluna Announces Monthly Business Update
ALBANY, N.Y.--(BUSINESS WIRE)--Soluna Holdings, Inc. (“Soluna” or the “Company”) (NASDAQ: SLNH), a developer of green data centers for intensive computing applications, including Bitcoin mining and AI, announced its January 2026 project site-level operations, developments, and updates. The Company has provided the following Corporate and Site Updates. Key Company Metrics: The monthly metrics are now available here. Corporate Highlights: Soluna and Siemens collaborate to address GPU power volati...
-
KUBRA Expands KUBRA EZ-PAY+™ To Support Every Type of Payment Obligation
TEMPE, Ariz.--(BUSINESS WIRE)--Organizations can now accept any payment obligation, from utilities and permits to donations and tickets, through one trusted experience....
-
Belden Reports Record Fourth Quarter and Full Year 2025 Results
ST. LOUIS--(BUSINESS WIRE)--Belden Inc. (NYSE: BDC) (“Belden” or the “Company”), a leading global supplier of specialty networking solutions, today reported fiscal fourth quarter and full year results for the period ended December 31, 2025. Fourth Quarter 2025 Highlights Record Revenues of $720 million, up 8% y/y and up 5% y/y organically GAAP EPS of $1.70, up 20% y/y Record Adjusted EPS of $2.08, up 8% y/y Repurchased 0.4 million shares for $45 million during the quarter Full Year 2025 Highlig...
-
Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – INO
LOS ANGELES--(BUSINESS WIRE)--Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – INO...
-
USA TODAY Co. Schedules Fourth Quarter 2025 Results
New York, NY--(BUSINESS WIRE)--USA TODAY Co., Inc. (“USA TODAY Co.”, “we”, “our”, or the “Company”) (NYSE: TDAY) announced today that it will release its fourth quarter 2025 financial results on Thursday, February 26, 2026, prior to the opening of the New York Stock Exchange. Management will host a conference call on Thursday, February 26, 2026 at 8:30 A.M. Eastern Time to review the financial and operating results for the period. A copy of the earnings release will be posted to the Investor Re...